Designs for Group Sequential Phase II Clinical Trials

DOI10.2307/2531540zbMath0715.62244WikidataQ52583941 ScholiaQ52583941MaRDI QIDQ3201547

Terry M. Therneau, Stephan S. Cha, Myron N. Chang, Harry S. Wieand

Publication date: 1987

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2531540

zbMATH Keywords

clinical trials; optimal design

Mathematics Subject Classification ID

62P10: Applications of statistics to biology and medical sciences; meta analysis

62L05: Sequential statistical design

Related Items

MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION, Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials, On the maximum total sample size of a group sequential test about bivariate binomial propor\-tions, Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity, On Bayesian estimators in multistage binomial designs, A review of phase 2-3 clinical trial designs, On the maximum total sample size of a group sequential test about binomial proportions., Methodology and application of adaptive and sequential approaches in contemporary clinical trials, Two-Stage Designs with Additional Futility Tests for Phase II Clinical Trials with Heterogeneous Patient Populations